Assessing the comparative value of sedatives in the intensive care unit.
Cox
Christopher E
CE
Govert
Joseph A
JA
D017046:Cost Savings / Q000191:economics; D003362:Cost-Benefit Analysis; D003422:Critical Care / Q000191:economics* / Q000379:methods; D020927:Dexmedetomidine / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D007362:Intensive Care Units / Q000191:economics; D008134:Long-Term Care / Q000191:economics / Q000379:methods; D008874:Midazolam / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D012121:Respiration, Artificial / Q000191:economics / Q000379:methods
D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine; D008874:Midazolam